Chongqing Genrix Biopharmaceutical Co., Ltd. (SHA:688443)
China flag China · Delayed Price · Currency is CNY
31.20
+0.13 (0.42%)
At close: May 12, 2026

SHA:688443 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
1,3181,5382,0352,89249.2814.15
Trading Asset Securities
832.54681.23412.5827.71237.36427.11
Cash & Short-Term Investments
2,1512,2192,4482,920286.64441.25
Cash Growth
-10.49%-9.36%-16.16%918.65%-35.04%684.19%
Accounts Receivable
37.921.0812.01---
Other Receivables
3.23.271.380-1.53
Receivables
41.1124.3513.380-1.53
Inventory
105.7496.1250.1555.4556.3333.66
Other Current Assets
114.26103.86110.5956.5656.0352.76
Total Current Assets
2,4122,4432,6223,032399529.2
Property, Plant & Equipment
501.47482.76441.55487.82487.75327.83
Other Intangible Assets
42.7142.6943.5943.5445.0845.92
Long-Term Deferred Charges
18.5620.1725.1627.9225.5123.51
Other Long-Term Assets
4.244.4113.263.464.7776.36
Total Assets
2,9792,9933,1463,595962.111,003
Accounts Payable
111.795.4367.0683.0467.8446.61
Accrued Expenses
58.3273.6563.0337.7429.7124.29
Short-Term Debt
23.92--0.63--
Current Portion of Long-Term Debt
174.92169.8826.24-5.30.9
Current Portion of Leases
--12.1310.077.646.51
Current Income Taxes Payable
1.735.98----
Current Unearned Revenue
114.52114.52----
Other Current Liabilities
19.1313.265.825.415.877.7
Total Current Liabilities
504.25472.72174.29136.87126.3786.01
Long-Term Debt
990.13884.82786.13608.48738.59535.55
Long-Term Leases
6.97.9812.6321.8230.3728.65
Long-Term Unearned Revenue
42.1543.0446.6243.237.6935.55
Other Long-Term Liabilities
-----5.08
Total Liabilities
1,5431,4091,020810.36933.03690.84
Common Stock
366.68366.68366.68366.68275275
Additional Paid-In Capital
4,1924,1924,1924,038573.29279.82
Retained Earnings
-3,103-2,953-2,418-1,621-819.21-242.84
Treasury Stock
-20.3-20.3-14.67---
Shareholders' Equity
1,4351,5852,1262,78429.08311.98
Total Liabilities & Equity
2,9792,9933,1463,595962.111,003
Total Debt
1,1961,063837.13640.99781.91571.6
Net Cash (Debt)
954.841,1561,6112,279-495.27-130.35
Net Cash Growth
-35.60%-28.22%-29.31%---
Net Cash Per Share
2.613.154.387.11-1.80-0.47
Filing Date Shares Outstanding
364.4366.68366.68366.68275275
Total Common Shares Outstanding
364.4366.68366.68366.68275275
Working Capital
1,9081,9712,4482,895272.63443.19
Book Value Per Share
3.944.325.807.590.111.13
Tangible Book Value
1,3931,5422,0822,741-15.99266.06
Tangible Book Value Per Share
3.824.215.687.47-0.060.97
Buildings
--115.03114.98105.8999.77
Machinery
--516.53457.63302.65261.93
Construction In Progress
--6.7452.18164.8218.27
Source: S&P Global Market Intelligence. Standard template. Financial Sources.